U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.
Philips faces challenges in China, but its overall fundamentals remain strong, with significant growth potential in other markets and segments like cardiovascular and ultrasound. Despite a 17% share price drop, Philips is undervalued at €24.20/share, presenting a compelling investment opportunity with an expected 11% annual EPS growth. The company shows margin improvements and resilience in various segments, indicating effective price hikes and operational adjustments amidst market uncertainties.
Investors looking for stocks in the Medical - Products sector might want to consider either Royal Philips (PHG) or ResMed (RMD). But which of these two stocks offers value investors a better bang for their buck right now?
Roy Jakobs, CEO of Royal Philips, joins Oliver Renick to sift through the company's latest quarterly figures. Shares of PHG (@Philips) tumbled in premarket trading as the company cut its guidance due to "significant deterioration" in China demand.
Koninklijke Philips N.V. (NYSE:PHG ) Q3 2024 Results Conference Call October 28, 2024 5:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Charlotte Hanneman - CFO Conference Call Participants Richard Felton - Goldman Sachs Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Lisa Clive - Bernstein Graham Doyle - UBS Hugo Solvet - Exane BNP Paribas Julien Dormois - Jefferies Robert Davies - Morgan Stanley Falko Friedrichs - Deutsche Bank Ed Ridley-Day - Redburn Leandro Mazzoni Hi, everyone.
American depositary receipts (ADRs) of Koninklijke Philips (PHG) are tumbling more than 15% in premarket trading Monday after the Dutch conglomerate cut its 2024 sales outlook amid a "significant deterioration" in Chinese demand.
On Monday, Koninklijke Philips NV PHG reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros.
It's a reminder of how sluggish demand in the world's second-largest economy could cause problems for the likes of Starbucks and Marriott.
Shares of Philips slumped on Monday as the Dutch healthcare devices company lowered its sales outlook for the year.
Roy Jakobs, CEO of Philips, discusses the health care device maker's third-quarter results.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.